spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  BioFlo 

 HSMN NewsFeed - 28 Aug 2017
ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jul 2014
AngioDynamics Awarded Novation Innovative Technology Contract Covering BioFlo PICCs and BioFlo Ports
Devices Group Purchasing
 HSMN NewsFeed - 18 Jun 2014
AngioDynamics Announces FDA Clearance for Celerity Tip Location System
Devices FDA
 HSMN NewsFeed - 7 Mar 2014
AngioDynamics Receives FDA Clearance for DuraMax Dialysis Catheter With BioFlo Technology to Reduce Catheter-Related Thrombus
Devices FDA
 HSMN NewsFeed - 3 Oct 2013
AngioDynamics Announces First Patient Enrolled in PICC Related Obstruction of Flow (PROOF) Study
Devices
 HSMN NewsFeed - 23 Sep 2013
AngioDynamics Extends Licensing Agreement With Interface Biologics to Include Central Venous Catheters (CVCs)
Devices Licensing
 HSMN NewsFeed - 20 Aug 2013
AngioDynamics Earns FDA Clearance for Ports With BioFlo Technology to Reduce Catheter-Related Thrombus
Devices FDA
 HSMN NewsFeed - 27 Jun 2013
AngioDynamics Announces FDA Clearance for Xcela Plus Port Family With PASV Technology
Devices FDA
 HSMN NewsFeed - 30 May 2013
Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Aug 2012
AngioDynamics Earns FDA Clearance for First Vascular Access Product With BioFlo Technology to Reduce Catheter-Related Thrombus
Devices FDA
 HSMN NewsFeed - 31 Jan 2012
AngioDynamics to Acquire Navilyst Medical for $372 Million
Devices Mergers & Acquisitions
 HSMN NewsFeed - 18 May 2011
Industry’s First Hybrid Drug-Eluting Stent from BIOTRONIK Demonstrates Safety and Efficacy in First-in-Man Clinical Experience
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jun 2007
Endovasc Announces Formation of BioFlow, Inc.
Devices
 HSMN NewsFeed - 17 Apr 2007
Erimos Pharmaceuticals Names Dr. Scott Mohrland as President and Chief Executive Officer
Biopharmaceuticals Personnel
Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!